Skip to main content
. 2018 Jun 19;84(9):1883–1905. doi: 10.1111/bcp.13624

Table 5.

Characteristics and key findings of included mixed‐methods studies (n = 3)

Author (year of publication) Aim(s)/objective(s) Definition and model of PP discussed Country of focus Stakeholder population studied (sample size) Study design and methods Key findings
Preimplementation of PP
Hanes and Bajorek (2005) 81 Explore the views of a sample of Australian hospital pharmacists on prescribing privileges Provided a definition for dependent prescribing Australia Hospital pharmacists (n = 10) and teacher practitioners (n = 5; 15 completed the questionnaire, 8 participated in the focus groups) Questionnaire and focus group Benefits include more efficient/improved pharmaceutical care and reduced healthcare costs. Physician opposition was a barrier. Training and accreditation beyond registration was deemed necessary.
Vracar and Bajorek (2008) 82 Explore Australian GPs' views on extending prescribing rights to pharmacists, the appropriateness of PP models, and the influence of GPs' characteristics on their preference for a particular PP model An overview of international models presented Australia Doctors (150 approached, 22 filled the questionnaire and 10 participated in the interview) Questionnaire and semistructured interview Repeat prescribing and prescribing by referral were the most favoured. Safety issues, lack of awareness of pharmacist training and capabilities, clinical responsibility, GP–patient relationship and remuneration were raised.
Postimplementation of PP
Baqir (2010) 80 Evaluate the extent of PP and identify some of the barriers to maintaining and developing such services No standardized definition provided UK Pharmacists who undertook a prescribing course (179 were invited to participate, 98 filled the questionnaire but not clear how many were involved in the focus groups) Multiple methods:
questionnaire, focus groups, documents review and interviews
In secondary care, easy access to medical records and prescription pads as well as close working relationships with doctors were facilitators. The major barrier was lack of a clear strategy at organizational level.

PP: pharmacist prescribing; GP, general practitioner